EGFR and non-small cell lung carcinoma: In this study, we investigated the expression profiles of miRNAs in EGFR-mutated NSCLC patients with either dramatic responses or primary resistance to EGFR-TKI therapy, and explored which miRNA may play a role in primary resistance to EGFR-TKIs in EGFR-mutant patients.